drugset

drugset / Trial / NCT03498703

Azathioprine in Recurrent Implantation Failure

NCT03498703 ↗

Phase 2 Completed 64 enrolled Ain Shams University Capital Birth Center · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

Azathioprine increase pregnancy rate in patients with recurrent implantation failure

Timeline

Start: 2018-04-25
Primary completion: 2019-07-01
Completion: 2019-07-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Azathioprine	Small molecule	—	Oral

Indications